NHC insider buying and SEC filings, explained
National Healthcare Corp. · CIK 1047335
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Insider activity in the last 12 months
Bought
$175K
Insiders who bought
1
Sold (not marked 10b5-1)
$11.2M
Planned sales (10b5-1)
$0
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Sep 22, 2026 | Sale | Vicki L Dodson (Sr.VP Patient Srvcs) sold 4,834 shares at $225.00 ($1.1M). Holdings down 31% to 10,726 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Sep 23, 2026 |
| Sep 11, 2026 | Sale | Brian F. Kidd (CFO) sold 6,813 shares at $225.70 ($1.5M). Holdings down 23% to 23,183 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Sep 14, 2026 |
| Sep 10, 2026 | Sale | Josh A McCreary (Senior VP & General Counsel) sold 2,719 shares at about $224.23 ($610K). Holdings down 21% to 9,979 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Sep 14, 2026 |
| Aug 12–28, 2026 | Sale | Ben Anderson Flatt Sr. (Senior VP & CIO) sold 7,000 shares between Aug 12 and Aug 28 at about $227.57 ($1.6M). Holdings down 31% to 15,636 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Sep 2, 2026 |
| Aug 25, 2026 | Sale | David R. Gifford (Director) sold 1,779 shares at $225.42 ($401K). Holdings down 63% to 1,030 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Aug 28, 2026 |
| Aug 19, 2026 | Sale | Stephen Fowler Flatt (CEO and Director) sold 1,500 shares at $237.08 ($356K). Holdings down 2% to 65,487 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Aug 20, 2026 |
| Jun 22, 2026 | Sale | Emil E. Hassan (Director) sold 5,937 shares at $200.00 ($1.2M). Holdings down 8% to 65,595 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jun 23, 2026 |
| Jun 16, 2026 | Sale | Emil E. Hassan (Director) sold 1,563 shares at $199.98 ($313K). Holdings down 2% to 71,532 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jun 18, 2026 |
| Jun 1, 2026 | Purchase (code P) | Lisa Piercey (Director) bought 949 shares at $184.26 ($175K), reported as a purchase (code P). New position of 949 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jun 2, 2026 |
| May 21, 2026 | Sale | Richard F. Laroche Jr. (Director) sold 7,500 shares at $195.14 ($1.5M). Holdings down 4% to 205,760 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed May 22, 2026 |
| May 19, 2026 | Sale | Timothy J. Shelly (Sr.VP Operations) sold 1,853 shares at $197.22 ($365K). Holdings down 59% to 1,294 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed May 20, 2026 |
| Dec 17, 2025 | Sale | Timothy J. Shelly (Sr.VP Operations) sold 2,454 shares at $139.42 ($342K). Holdings down 100% to 0 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Dec 18, 2025 |
| Nov 25, 2025 | Sale | Emil E. Hassan (Director) sold 7,500 shares at $138.52 ($1.0M). Holdings down 10% to 65,595 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Nov 26, 2025 |
| Nov 21, 2025 | Sale | Stephen Fowler Flatt (CEO and Director) sold 1,000 shares at $130.33 ($130K). Holdings down 2% to 59,130 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Nov 25, 2025 |
| Nov 12, 2025 | Sale | Emil E. Hassan (Director) sold 5,500 shares at $133.00 ($732K). Holdings down 7% to 73,095 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Nov 12, 2025 |
62 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
No cluster buys in the last 12 months.
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
No 8-K filings in the last 12 months.
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow NHC in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.